Localising and automating supply chains will allow companies to mitigate the impact of tariffs and minimise resulting costs.

Following today’s release of DFS’ figures for the 52 weeks ending 29 June 2025; Matt Walton, senior retail analyst at ...

Grenke has become the 40th organisation to join Acquis Lumia, an industry-wide register of asset finance borrowing created to ...

The success of the post-growth model is reliant on transparency, clear and honest communication with customers and supplier collaboration.

"AstraZeneca’s AL amyloidosis drug fails to impress in Phase III" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Subaru’s latest campaign highlights hybrid and EV models, tying sustainability, safety and versatility to evolving demands in ...

Canada's convenience store giant backed away from a blockbuster bid set to dramatically expanded its convenience store empire ...

The California High-Speed Rail Authority has called the move to remove $4bn of allocated federal funding "illegal".

OKYO Pharma has reported encouraging top-line outcomes from the randomised Phase II trial of urcosimod to treat NCP.

Already in build, the testbed aircraft is supposed to fly within the next three years in a bid to deliver to first GCAP fighter by 2035.